Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Samuel D. Colella currently holds 11,198 shares of Flexion Therapeutics Inc (FLXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel D. Colella has been a net buyer of FLXN stock. They have purchased $16.7M and sold $7.4M worth of shares.
Samuel D. Colella's most recent insider trade was on Nov 19, 2021, when they sold 994,129 shares at $8.50 per share.
Samuel D. Colella serves as Executive at Flexion Therapeutics Inc (FLXN). They have executed 247 insider transactions totaling $24.2M over their tenure at the company.
Samuel D. Colella holds the position of Executive at Flexion Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Samuel D. Colella has shown a buying trading pattern, with $16.7M in total purchases and $7.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Samuel D. Colella was on Nov 19, 2021, when they sold $8.5M worth of FLXN shares. This transaction involved 994,129 shares at $8.50 per share.
Samuel D. Colella currently owns 11,198 shares of Flexion Therapeutics Inc (FLXN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Samuel D. Colella's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Samuel D. Colella has 247 Form 4 filings on record as an insider at Flexion Therapeutics Inc.
Set alerts for Samuel D. Colella and 40,000+ other insiders.